SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Ambev S.A. – ‘6-K’ for 3/31/20

On:  Monday, 2/10/20, at 5:00pm ET   ·   For:  3/31/20   ·   Accession #:  1292814-20-339   ·   File #:  1-36165

Previous ‘6-K’:  ‘6-K’ on 2/10/20 for 3/31/20   ·   Next:  ‘6-K’ on 2/26/20 for 3/31/20   ·   Latest:  ‘6-K’ on 4/9/24 for 6/30/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/10/20  Ambev S.A.                        6-K         3/31/20    1:96K                                    MZ Technologies/FA

Current Report by a Foreign Issuer   —   Form 6-K   —   Rule 13a-16 / 15d-16
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Current Report by a Foreign Issuer --               HTML     51K 
                ambevsacvm358jan2020_6k1                                         


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  ambevsacvm358jan2020_6k1.htm - Generated by SEC Publisher for SEC Filing  

 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
 
For the month of February, 2020

Commission File Number 1565025
 

 

AMBEV S.A.
(Exact name of registrant as specified in its charter)
 

AMBEV S.A.
(Translation of Registrant's name into English)
 

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


Form 20-F ___X___ Form 40-F _______

 Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____


 

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 358/2002

 

From January 1st to 31st, 2020 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002(1):

 

Company Name: Ambev S.A.

Group and Related Persons

( X )

Board of Directors

(   )

Management

(   )

Fiscal Council

(   )

Technical and Consulting Committees 

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

Shares

Common

33,337,417

ADR

Common

950,680

Transactions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price

Volume (R$) (3)

Shares

Common

Direct with the Company

Exerc Options

13

852,850

R$ 1.77036

R$ 1,509,851.53

 

 

 

Total Buy

 

852,850

 

 

 

 

 

 

 

 

 

 

Shares

Common

N/A

Donation

13

163,050

R$ 2.10500

R$ 343,219.98

 

 

 

Total Sell

 

163,050

 

R$ 343,219.98

 

 

 

 

 

 

 

 

ADR

Common

JP Morgan

Sell

22

828,501

R$ 18.79652

15,572,932.18

 

 

 

Total Sell

 

828,501

 

15,572,932.18

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

Shares

Common

34,027,217

ADR

Common

122,179

                       

 

 

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

 

(2)  Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(3)  Quantity multiplied by price.

 

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

 

Each ADR is equivalent to 1 (one) share.

 

 


 

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 358/2002

 

From January 1st to 31st, 2020 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002(1):

 

 

Company Name: Ambev S.A.

Group and Related Persons

(   )

Board of Directors

( X )

Management

(   )

Fiscal Council

(   )

Technical and Consulting Committees 

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

Shares

Common

7,056,863

ADR

Common

221,570

Transactions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price

Volume (R$) (3)

Shares

Common

N/A

Renounce

01

1,746,287

R$ 0.00

R$ 0.00

Shares

Common

Direct with the Company

Sell

02

300,000

R$ 19.20

R$ 5,760,000.00

 

 

 

Total Sell

 

2,046,287

 

R$ 5,760,000.00

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

Shares

Common

5,010,576

ADR

Common

221,570

                         

 

 

 

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

 

(2)  Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(3)  Quantity multiplied by price.

 

 

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

 

Each ADR is equivalent to 1 (one) share.


 

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 358/2002

 

 

From January 1st to 31st, 2020 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002(1):                                      

 

Company Name: Ambev S.A.

Group and Related Persons

(   )

Board of Directors

(   )

Management

( X )

Fiscal Council

(   )

Technical and Consulting Committees 

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

Shares

Common

7,225

Transactions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price

Volume (R$) (3)

 

 

 

 

 

 

 

 

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

Shares

Common

7,225

                         

 

 

(1)   When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

 

(2)   Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(3)  Quantity multiplied by price.

 

 

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

 

 

 

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: February 10, 2020
     
 
AMBEV S.A.
     
 
By: 
 
Chief Financial and Investor Relations Officer
 
 
 
 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘6-K’ Filing    Date    Other Filings
For Period end:3/31/206-K
Filed on:2/10/206-K
 List all Filings 
Top
Filing Submission 0001292814-20-000339   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 16, 2:03:33.2pm ET